SCHEMBL21586947

SCHEMBL21586947

CC(C)(C)c1cc(OCCCO)cc(-n2nc3ccc(Cl)cc3n2)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 2/20 0.36
PDE10A Q9Y233 2/20 0.36
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 3/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK1 P28482 2/20 0.32
HTT P42858 1/20 0.32
ACSS2 Q9NR19 1/20 0.31
NR1H4 Q96RI1 1/20 0.31
GAA P10253 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
NUDT1 P36639 1/20 0.31
BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30887157 1.00 PDE2A (0.36) PDE2APDE10ANPC1RAB9ALMNA
SCHEMBL21586951 0.92 PDE2A (0.35) PDE2ANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL23638712 0.88 NPC1 (0.37) NPC1RAB9ALMNAALDH1A1KDM4E
SCHEMBL21586965 0.88 NPC1 (0.40) PDE2ANPC1RAB9ALMNAALDH1A1
SCHEMBL8441278 0.87 CA1 (0.39) NPC1RAB9ALMNAALDH1A1SMN1; SMN2
SCHEMBL21586968 0.86 ATP4A (0.41) PDE2AKMT2A
SCHEMBL9513087 0.86 KDM4E (0.32) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL15393589 0.85 SRC (0.33) PDE2AKDM4EACSS2
SCHEMBL24913928 0.85 ALDH1A1 (0.32) LMNAALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL9620532 0.85 CA1 (0.42) PDE2APDE10ANPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578550-B1 NOVEL RED-SHIFTING BENZOTRIAZOLE UV ABSORBERS EVERLIGHT CHEM IND CORP (TW) 2023-08-16 EP disclosed
EP-3848357-B1 REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF EVERLIGHT CHEM IND CORP (TW) 2023-01-18 EP disclosed
US-20210214321-A1 NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) 2021-07-15 US disclosed
EP-3848357-A1 REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF Everlight Chemical Industrial Corporation (TW) 2021-07-14 EP disclosed
EP-3578550-A1 NOVEL BENZOTRIAZOLE UV ABSORBER WITH RED SHIFT AND USE THEREOF Everlight Chemical Industrial Corporation (TW) 2019-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214321-A1 NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF SULT1A1, XDH, SULT2A1 PDE2A 3792/4885PDE10A 3829/4885NPC1 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.